Dexmedetomidine has been associated with less respiratory depression or gastrointestinal dysmotility when compared to fentanyl [134], and there is some suggestion that the use of alpha-2 agonists such as dexmedetomidine may be neuroprotective [135]. The gene discussed is PSMA2; the disease is Gastrointestinal dysmotility.